Trial Profile
A Phase I Study of ZD0473 and Doxil [liposomal doxorubicin] in Patients With Advanced Refractory Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Jun 2008
Price :
$35
*
At a glance
- Drugs Picoplatin (Primary) ; Doxorubicin liposomal
- Indications Ovarian cancer
- Focus Adverse reactions
- 06 Jun 2008 Status changed rom recruiting to completed as reported in ASCO abstract.
- 06 Jun 2008 Final results presented as ASCO 2008.
- 03 Sep 2005 New trial record.